What is Jyong Biotech Ltd. Ordinary Shares?
, a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 133.81M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.